Helminthic therapy and osteoporosis

    From Helminthic Therapy wiki

    Osteoporosis is a metabolic bone disease - a systemic skeletal disorder characterized by low bone mass (osteopenia) and more porous bone. It commonly affects older adults, particularly postmenopausal women, and involves the progressive deterioration of bone tissue over time with a consequent increase in the risk of fractures.

    Osteoporosis has no symptoms, and a person usually does not know they have the disorder until a bone breaks. It is also more prevalent among the elderly who are statistically less likely to be aware of helminthic therapy and open to using it, factors which may partly explain why there have been no reports to date from individuals with osteoporosis about their use of helminthic therapy.

    The scientific evidence[edit | edit source]

    Quotein.gif
    Here, we show that infection with the natural mouse helminth parasite, Heligmosomoides polygyrus bakeri (Hp) not only attenuates the development of arthritis in two different inflammatory arthritis mouse models (...) but also impacts positively on systemic bone metabolism.

    See also

    Age-associated inflammation is responsible for the decline in the number and function of the skeletal stem cells that enable bones to heal.

    Helminths that promote bone loss